Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles (2010 - 2026)

Cumberland Pharmaceuticals has reported Amortization - Intangibles for 17 years, with the latest figure at $1.2 million in Q1 2026.

• Quarterly Amortization - Intangibles rose 24.23% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 7.85% YoY) and the FY2025 annual result came in at $4.0 million, down 15.03% from the prior year.
• Amortization - Intangibles improved to $1.2 million in Q1 2026 per CPIX's latest filing, from $1.0 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $4.5 million in Q4 2023 and troughed at $458222.0 in Q4 2022.
• A 5-year average of $1.4 million and a median of $1.2 million in 2023 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2023 and 2024: Amortization - Intangibles surged 890.6% in 2023, then slumped 67.85% in 2024.
• Over 5 years, Amortization - Intangibles stood at $458222.0 in 2022, then soared by 890.6% to $4.5 million in 2023, then tumbled by 67.85% to $1.5 million in 2024, then sank by 30.57% to $1.0 million in 2025, then gained by 23.26% to $1.2 million in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $1.2 million, $1.0 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.